Hemostats Market Research Report – Forecast to 2027

Hemostats Market: Product Type (Thrombin Based, Collagen Based, Tissue Sealants- Fibrin Sealants, and Others), Instrument Type (Halstead Mosquito Hemostatic Forceps,), Application (Gynecology, Neurology, Cardiovascular) - Forecast Till 2027

ID: MRFR/MED/4952-HCR | February 2021 | Region: Global | 100 pages

Hemostats Market Scenario


The hemostats market is expected to register a 6.4% growth during the forecast period (2018–2023).


Blood loss occurs in surgeries due to the damage of blood vessels. It is vital to coalesce the blood to avoid too much of blood loss. The formation of blood clots at the site of injury is called hemostasis. Hemostats are surgical tools that are used during surgeries to control the bleeding of the patient. These surgical instruments help to temporarily form blood clots to control bleeding. The hemostat is also known as a hemostatic clamp and arterial forceps. It is fundamentally used in the early phases of surgery for a preliminary incision that closes blood vessels till ligation.  Tissue sealants and tissue adhesion agents are very helpful for the application of hemostats.  


The growing number of surgical procedures, continuous progression in products range, rising incidences of sports-related damages, spinal disorders, technological advancements and increasing focus on effective blood loss management in patients during surgeries are the chief factors to boosts the hemostats market. Also, the emerging markets and rise in the number of hospitals and surgical centers are anticipated to offer added growth opportunities for players operating in the hemostats market. However, the high cost of hemostats, government’s rules and regulations and lack of skilled professionals is expected to hamper the growth of hemostats market.


Segmentation


The hemostats market has been segmented on the basis of product type, instrument type, application, and end-user.


On the basis of product type, the market has been classified as thrombin-based, combination based, oxidized regenerated cellulose-based, gelatin based, collagen-based hemostat, tissue sealants, cyanoacrylate-based tissue adhesives, adhesion prevention products. The tissue sealants have been segmented into fibrin sealants, protein-based sealants.


On the basis of instrument type, the market has been classified as halstead mosquito hemostatic forceps, kelly and crile hemostatic forceps, and rochester-carmalt hemostatic forceps.


On the basis of application, the market has been classified as cardiovascular surgery, general surgery, gynecological surgery, reconstructive surgery, neurological surgery, orthopedic surgery, and other surgeries.


On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory surgery centers, community healthcare, and others.


On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.


The European hemostats market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The hemostats market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The hemostats market in the Middle East and Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Hemostats Market Share, by Region, 2017 (%)


Hemostats Market Share


Source: MRFR Analysis


In the hemostats market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures. According to the National Health Statistics Report by the Centers of Disease Control & Prevention, in 2014, about 201,748.3 million surgical procedures were carried out in the U.S. The statistics also showed that 28.6 million appointments to ambulatory surgery cases were informed in the U.S.


The European market is expected to hold the second largest market share. The market growth in this region can be attributed to growing frequency of cardiovascular disorders, increasing number of surgeries and rising demand for advanced treatment procedures are boosting the European market.


The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism.


The market in the Middle East and Africa is expected to account for the smallest share of the global hemostats market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the global hemostats market are CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany), Anika Therapeutics, Inc. (US), Stryker (US), and Integra Lifesciences Corporation(US).


Hemostats Market, by Product Type



  • Thrombin based

  • Combination-based

  • Oxidized regenerated cellulose based

  • Gelatin-based

  • Collagen-based hemostat

  • Tissue sealant

  • Fibrin sealants

  • Protein-based sealants

  • Cyanoacrylate-based tissue adhesives

  • Adhesion prevention products


Hemostats Market, by Instrument Type



  • Halstead mosquito hemostatic forceps

  • Kelly and Crile hemostatic forceps

  • Rochester-carmalt hemostatic forceps


Hemostats Market, by Application Type



  • Cardiovascular surgery

  • General surgery

  • Gynecological surgery

  • Reconstructive surgery

  • Neurological surgery

  • Orthopedic surgery

  • Other surgeries


Hemostats Market, by End-Users



  • Hospitals

  • Clinics

  • Ambulatory surgery centers

  • Community healthcare

  • Others


Hemostats Market, by Region



  • Americas

    • North America

    • US

    • Canada

    • South America



  • Europe

    • Western Europe

    • Germany

    • France

    • Italy

    • Spain

    • UK

    • Rest of Western Europe

    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Advanced Surgical Trainees

  • Governmental Agency

  • Educational Organizations

  • Medical Device Manufacturers

  • Research Institutes and Academic Centers

  • Market Research and Consulting



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   6.4% (2018-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Type, Instrument type, Application, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany), Anika Therapeutics, Inc. (US), Stryker (US), and Integra Lifesciences Corporation(US).
  Key Market Opportunities   Rise in the number of hospitals and surgical centers
  Key Market Drivers

  • Growing number of surgical procedures
  • Continuous progression in products range
  • Rising incidences of sports-related damages
  • Spinal disorders
  • Technological advancements
  • Increasing focus on effective blood loss management


  • Frequently Asked Questions (FAQ) :


    Blood loss occurs in surgeries due to the damage of blood vessels. It is vital to coalesce the blood to avoid too much of blood loss. The formation of blood clots at the site of injury is called hemostasis.

    Hemostats are surgical tools that are used during surgeries to control the bleeding of the patient. These surgical instruments help to temporarily form blood clots to control bleeding. The hemostat is also known as a hemostatic clamp and arterial forceps. It is fundamentally used in the early phases of surgery for a preliminary incision that closes blood vessels till ligation.

    The Hemostats Market is expected to exhibit a strong 6.4% CAGR over the forecast period from 2018 to 2023.

    Growing number of surgical procedures around the world is the major driver for the hemostats market.

    Americas hold the major share in the hemostats market, followed by Europe.

    Leading players in the Hemostats Market include C.R. Bard, Stryker, and Pfizer, among others.

    Table of Contents:

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Hemostats Market, by Product Type

    6.1 Introduction

    6.2 Thrombin based

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3 Combination based

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.4 Oxidized regenerated cellulose based

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.5 Gelatin based

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.6 Collagen-based

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.7 Tissue sealant

    6.7.1 Fibrin sealants

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.7.2 Protein-based sealants

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.8 Cyanoacrylate-based tissue adhesives

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.9 Adhesion prevention products

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 7. Global Hemostats Market, by Instrument Type

    7.1 Introduction

    7.2 Halstead mosquito hemostatic forceps

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3 Kelly and Crile hemostatic forceps

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.4 Rochester-carmalt hemostatic forceps

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 8. Global Hemostats Market, by Application

    8.1 Introduction

    8.2 Cardiovascular surgery

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3 General surgery

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4 Gynecological surgery

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.5 Reconstructive surgery

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.6 Neurological surgery

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.7 Orthopedic surgeries

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.8 Other surgeries

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 9. Global Hemostats Market, by End-Users

    9.1 Introduction

    9.2 Hospitals

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.3 Clinics

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.4 Ambulatory Surgery Centers

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.5 Community healthcare

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.6 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 10. Global Hemostats Market, by Region

    10.1 Introduction

    10.2 Americas

    10.2.1 North America

    10.2.1.1 US

    10.2.1.2 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 Italy

    10.3.1.4 Spain

    10.3.1.5 UK

    10.3.1.6 Rest of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia-Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 South Korea

    10.4.6 Rest of Asia-Pacific

    10.5 Middle East & Africa

    10.5.1 Middle East

    10.5.2 Africa

    Chapter 11. Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    Chapter 12. Company Profiles

    12.1 CR Bard, Inc.

    12.1.1 Company Overview

    12.1.2 Product Type Overview

    12.1.3 Financials Overview

    12.1.4 Key Developments

    12.1.5 SWOT Analysis

    12.2 B. Braun Melsungen AG

    12.2.1 Company Overview

    12.2.2 Product Type Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.2.5 SWOT Analysis

    12.3 Baxter International, Inc.

    12.3.1 Company Overview

    12.3.2 Product Type Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 Integra LifeSciences

    12.4.1 Company Overview

    12.4.2 Technology/Business Segment Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 Marine Polymer Technologies, Inc.

    12.5.1 Company Overview

    12.5.2 Product Type Overview

    12.5.3 Financial overview

    12.5.4 Key Developments

    12.5.5 SWOT Analysis

    12.6 Teleflex

    12.6.1 Company Overview

    12.6.2 Product Type Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.6.5 SWOT Analysis

    12.7 Ethicon, Inc.

    12.7.1 Overview

    12.7.2 Product Type Overview

    12.7.3 Financial Overview

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    12.8 Pfizer, Inc.

    12.8.1 Overview

    12.8.2 Product Type/ Technology Overview

    12.8.3 Financials

    12.8.4 Key Developments

    12.8.5 SWOT Analysis

    12.9 Z-Medica LLC

    12.9.1 Overview

    12.9.2 Product Type Overview

    12.9.3 Financials

    12.9.4 Key Developments

    12.9.5 SWOT Analysis

    12.10 Gelita Medical GmbH

    12.10.1 Overview

    12.10.2 Product Type Overview

    12.10.3 Financials

    12.10.4 Key Developments

    12.10.5 SWOT Analysis

    12.12 Anika Therapeutics, Inc.

    12.12.1 Overview

    12.12.2 Product Type Overview

    12.12.3 Financials

    12.12.4 Key Developments

    12.12.5 SWOT Analysis

    12.12 Stryker

    12.12.1 Overview

    12.12.2 Product Type Overview

    12.12.3 Financials

    12.12.4 Key Developments

    12.12.5 SWOT Analysis

    Chapter 13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s Viewpoint

    13.1.2 Unmet Needs of the Market

    13.2 Key Companies to Watch

    13.3 Predictions for the Global Hemostats Market Industry

    Chapter 14. Appendix

    LIST OF TABLES

    Table 1 Global Hemostats Market Synopsis, 2020-2027

    Table 2 Global Hemostats Market Estimates and Forecast, 2020-2027 (USD Million)

    Table 3 Global Hemostats Market, by Region, 2020-2027 (USD Million)

    Table 4 Global Hemostats Market, by Product Type, 2020-2027 (USD Million)

    Table 5 Global Hemostats Market, by Instrument Type, 2020-2027 (USD Million)

    Table 6 Global Hemostats Market, by Application, 2020-2027 (USD Million)

    Table 7 Global Hemostats Market, by End-users, 2020-2027 (USD Million)

    Table 8 North America: Global Hemostats Market, by Product Type, 2020-2027 (USD

    Million)

    Table 9 North America: Global Hemostats Market, by Instrument Type, 2020-2027 (USD

    Million)

    Table 10 North America: Global Hemostats Market, by Application, 2020-2027 (USD

    Million)

    Table 11 North America: Global Hemostats Market, by End-users, 2020-2027 (USD Million)

    Table 12 US: Global Hemostats Market, by Product Type, 2020-2027 (USD Million)

    Table 13 US: Global Hemostats Market, by Instrument Type, 2020-2027 (USD Million)

    Table 14 US: Global Hemostats Market, by Application, 2020-2027 (USD Million)

    Table 15 US: Global Hemostats Market, by End-users, 2020-2027 (USD Million)

    Table 16 Canada: Global Hemostats Market, by Product Type, 2020-2027 (USD Million)

    Table 17 Canada: Global Hemostats Market, by Instrument Type, 2020-2027 (USD Million)

    Table 18 Canada: Global Hemostats Market, by Application, 2020-2027 (USD

    Million)

    Table 19 Canada Global Hemostats Market, by End-users, 2020-2027 (USD Million)

    Table 20 South America: Global Hemostats Market, by Product Type, 2020-2027 (USD

    Million)

    Table 21 South America: Global Hemostats Market, by Instrument Type, 2020-2027 (USD

    Million)

    Table 22 South America: Global Hemostats Market, by Application, 2020-2027 (USD

    Million)

    Table 23 South America: Global Hemostats Market, by End-users, 2020-2027 (USD Million)

    Table 24 Europe: Global Hemostats Market, by Product Type, 2020-2027 (USD Million)

    Table 25 Europe: Global Hemostats Market, by Instrument Type, 2020-2027 (USD Million)

    Table 26 Europe: Global Hemostats Market, by Application, 2020-2027 (USD Million)

    Table 27 Europe: Global Hemostats Market, by End-users, 2020-2027 (USD Million)

    Table 28 Western Europe: Global Hemostats Market, by Product Type, 2020-2027 (USD

    Million)

    Table 29 Western Europe: Global Hemostats Market, by Instrument Type, 2020-2027 (USD

    Million)

    Table 30 Western Europe: Global Hemostats Market, by Application, 2020-2027

    (USD Million)

    Table 31 Western Europe: Global Hemostats Market, by End-users, 2020-2027 (USD Million)

    Table 32 Eastern Europe: Global Hemostats Market, by Product Type, 2020-2027 (USD

    Million)

    Table 33 Eastern Europe: Global Hemostats Market, by Instrument Type, 2020-2027 (USD

    Million)

    Table 34 Eastern Europe: Global Hemostats Market, by Application, 2020-2027

    (USD Million)

    Table 35 Eastern Europe: Global Hemostats Market, by End-users, 2020-2027 (USD Million)

    Table 36 Asia-Pacific: Global Hemostats Market, by Product Type, 2020-2027 (USD

    Million)

    Table 37 Asia-Pacific: Global Hemostats Market, by Instrument Type, 2020-2027 (USD

    Million)

    Table 38 Asia-Pacific: Global Hemostats Market, by Application, 2020-2027 (USD

    Million)

    Table 39 Asia-Pacific: Global Hemostats Market, by End-users, 2020-2027 (USD Million)

    Table 40 Middle East & Africa: Global Hemostats Market, by Product Type, 2020-2027

    (USD Million)

    Table 41 Middle East & Africa: Global Hemostats Market, by Instrument Type, 2020-2027

    (USD Million)

    Table 42 Middle East & Africa: Global Hemostats Market, by Application, 2020-2027

    (USD Million)

    Table 43 Middle East & Africa: Global Hemostats Market, by End-users, 2020-2027 (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Hemostats Market

    Figure 3 Segmentation Market Dynamics for Global Hemostats Market

    Figure 4 Global Hemostats Market Share, by Product Type, 2020

    Figure 5 Global Hemostats Market Share, by Instrument Type, 2020

    Figure 6 Global Hemostats Market Share, by Application, 2020

    Figure 7 Global Absorbable Surgical Sutures, by End-users, 2020-2027 (USD Million)

    Figure 8 Global Hemostats Market Share, by Region, 2020

    Figure 9 North America: Global Hemostats Market Share, by Country, 2020

    Figure 10 Europe: Global Hemostats Market Share, by Country, 2020

    Figure 11 Asia-Pacific: Global Hemostats Market Share, by Country, 2020

    Figure 12 Middle East & Africa: Global Hemostats Market Share, by Country, 2020

    Figure 13 Global Hemostats Market: Company Share Analysis, 2020 (%)

    Figure 14 CR Bard, Inc.: Key Financials

    Figure 15 CR Bard, Inc.: Segmental Revenue

    Figure 16 CR Bard, Inc.: Geographical Revenue

    Figure 17 B. Braun Melsungen AG: Key Financials

    Figure 18 B. Braun Melsungen: Segmental Revenue

    Figure 19 B. Braun Melsungen: Geographical Revenue

    Figure 20 Baxter International, Inc.: Key Financials

    Figure 21 Baxter International, Inc.: Segmental Revenue

    Figure 22 Baxter International, Inc.: Geographical Revenue

    Figure 23 Integra LifeSciences: Key Financials

    Figure 24 Integra LifeSciences: Segmental Revenue

    Figure 25 Integra LifeSciences: Geographical Revenue

    Figure 26 Marine Polymer Technologies, Inc.: Key Financials

    Figure 27 Marine Polymer Technologies, Inc.: Segmental Revenue

    Figure 28 Marine Polymer Technologies, Inc.: Geographical Revenue

    Figure 29 Teleflex: Key Financials

    Figure 30 Teleflex: Segmental Revenue

    Figure 31 Teleflex: Geographical Revenue

    Figure 32 Ethicon, Inc.: Key Financials

    Figure 33 Ethicon, Inc.: Segmental Revenue

    Figure 34 Ethicon, Inc.: Geographical Revenue

    Figure 35 Pfizer, Inc.: Key Financials

    Figure 36 Pfizer, Inc.: Segmental Revenue

    Figure 37 Pfizer, Inc.: Geographical Revenue

    Figure 38 Z-Medica LLC: Key Financials

    Figure 39 Z-Medica LLC: Segmental Revenue

    Figure 40 Z-Medica LLC: Geographical Revenue

    Figure 41 Gelita Medical GmbH: Key Financials

    Figure 42 Gelita Medical GmbH: Segmental Revenue

    Figure 43 Gelita Medical GmbH: Geographical Revenue

    Figure 44 Anika Therapeutics, Inc.: Key Financials

    Figure 45 Anika Therapeutics, Inc.: Segmental Revenue

    Figure 46 Anika Therapeutics, Inc.: Geographical Revenue

    Figure 47 Stryker: Key Financials

    Figure 48 Stryker: Segmental Revenue

    Figure 49 Stryker: Geographical Revenue